Distribution of Chlamydia pneumoniae infection in the atherosclerotic carotid artery

Stroke

Volumn 29, Issue 4, 1998, Pages 773-778

  Yamashita, Katsuhiro ^a,c   Ouchi, Kazunobu ^b   Shirai, Mutsunori ^a   Gondo, Toshikazu ^a   Nakazawa, Teruko ^a   Ito, Haruhide ^a  

^a YAMAGUCHI UNIVERSITY   (Japan)

^b Saiseikai Shimonoseki Gen Hospital   (Japan)

^c YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY;

ANTIGEN SPECIFICITY; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY; CAROTID ENDARTERECTOMY; CHLAMYDOPHILA PNEUMONIAE; CLINICAL ARTICLE; DISEASE ASSOCIATION; HUMAN; IMMUNOHISTOCHEMISTRY; INFECTION RISK; PRIORITY JOURNAL; RISK FACTOR; SMOOTH MUSCLE FIBER;

EID: 0031898734     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.29.4.773     Document Type: Article

References (42)

1. Leinonen M. Pathogenetic mechanisms and epidemiology of Chlamydia pneumoniae. Eur Heart J. 1993;14(suppl K):57-61.
2. Kanamoto Y, Ouchi K, Mizui M, Ushio M, Usui T. Prevalence of antibody to Chlamydia pneumoniae TWAR in Japan. J Clin Microbiol. 1991;29:816-818.
3. Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Makela PH, Huttonen JK, Valtonen V. Serological evidence of an association of a novel Chlamydia. TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 1988;2:983-986.
4. Thom DH, Grayston JT, Siscovick DS, Wang SP, Weiss NS, Daling JR. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA. 1992;268: 68-72.
5. Saikku P, Leinonen M, Tenkanen L, Linnanmaki E, Ekman MR, Manninen V, Manttari M, Frick MH, Huttunen JK. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med. 1992;116:273-278.
6. Grayston JT. Chlamydia in atherosclerosis. Circulation. 1993;87: 1408-1409.
7. Linnanmäki E, Leinonen M, Mattila K, Nieminen MS, Valtonen V, Saikku P. Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease. Circulation. 1993; 87:1130-1134.
8. Mendall MA, Carrington D, Strachan D, Patel P, Molineaux N, Levi J, Toosey T, Camm AJ, Northfield TC. Chlamydia pneumoniae: risk factors for seropositivity and association with coronary heart disease. J Infect. 1995;30:121-128.
9. Shor A, Kuo CC, Patton DL. Detection of Chlamydia pneumoniae in the coronary artery atheroma plaque. S Afr Med J. 1992;82:158-161.
10. Kuo CC, Shor A, Campbell LA, Fukushi H, Patton DL, Grayston JT. Demonstration of Chlamydia pneumaniae in atherosclerotic lesions of coronary arteries. J Infect Dis. 1993;167:841-849.
11. Kuo CC, Gown AM, Benditt EP, Grayston JT. Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Arterioscler Thromb. 1993;13:1501-1504.
12. Kuo CC, Grayston JT, Campbell LA, Goo YA, Wissler RW, Benditt EP. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc Natl Acad Sci U S A. 1995;92:6911-6914.
13. Campbell LA, O'Brien ER, Cappuccino AL, Kuo CC, Wang SP, Stewart D, Patton DL, Cummings PK, Grayston JT. Detection of Chlamydia pneumimiae TWAR in human coronary atherectomy tissues. J Infect Dis. 1995;172:585-588.
14. Muhlestein JB, Hammond EH, Carlquist JF, Radicke E, Thomson MJ, Karagounis LA, Woods ML, Anderson JL. Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerosis versus other forms of cardiovascular disease. J Am Coll Cardiol. 1996;27:1555-1561.
15. Jackson LA, Campbell LA, Kuo CC, Rodriguez DI, Lee A, Grayston JT. Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J Infect Dis. 1997;176:292-295.
16. Melnick SL, Shahar E, Folsom AR, Grayston JT, Sorlie PD, Wang SP, Szxlo M. Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Am J Med. 1993;95:499-504.
17. Grayston JT, Kuo CC, Coulson AS, Campbell LA, Lawrence RD, Lee MJ, Strandness ED, Wang SP. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation. 1995;92:3397-3400.
18. Wimmer MLJ, Sandmann-Strupp R, Saikku P, Haberl RL. Association of chlamydial infection with cerebrovascular disease. Stroke. 1996;27: 2207-2210.
19. Godzik KL, O'Brien ER, Wang SK, Kuo CC. In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae. J Clin Microbiol. 1995;33:2411-2414.
20. Gaydos CA, Summersgill JT, Sahney NN, Ramirez JA, Quinn TC. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immun. 1996;64:1614-1620.
21. Knoebel E, Vijayagopal P, Figueroa JE II, Martin DH. In vitro infection of smooth muscle cells by Chlamydia pneumoniae. Infect Immun. 1997; 65:503-506.
22. Hammerschlag MR, Chirgwin K, Roblin PM, Gelling M, Dumornay W, Mandel L, Smith P, Schachter J. Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin Infect Dis. 1992;14: 178-182.
23. Moazed TC, Kuo CC, Grayston JT, Campbell LA. Murine models of Chlamydia pneumoniae infection and atherosclerosis. J Infect Dis. 1997; 175:883-890.
24. Ross R. The pathogenesis of atherosclerosis: an update. N Engl J Med. 1986;314:488-500.
25. Kuo CC. Cultures of Chlamydia trachomatis in mouse peritoneal marophages: factors affecting organism growth. Infect Immun. 1978;20: 439-445.
26. Chen WJ, Kuo CC. A mouse model of pneumonitis induced by Chlamydia trachomatis: morphologic, microbiologic, and immunologic studies. Am J Pathol. 1980;100:365-377.
27. Saikku P. Chlamydia pneumoniae infection as a risk factor in acute myocardial infarction. Eur Heart J. 1993;14(suppl K):62-65.
28. Rothermel CD, Schachter J, Lavrich P, Lipsitz EC, Francus T. Chlamydia trachomatis-induced production of interleukin-1 by human monocytes. Infect Immun. 1989;57:2705-2711.
29. Kaukoranta-Tolvanen SS, Teppo AM, Leinonen M, Saikku P, Laitinen K. Chlamydia pneumoniae induces the production of TNF-α, IL-1β, and IL-6 by human monocytes. Proc Eur Soc Chlamydia Res. 1992;2:85.
30. Dinarello CA. Interleukin-1 and its biologically related cytokines. In: Cohen S, ed. Lymphokines and the Immune Response. Boca Raton, Fla: CRC Press; 1990: 145-179.
31. Sterpetti AV, Cucina A, Fragale A, Lepidi S, Cavallaro A, Santoro-D'Angelo L. Shear stress influences the release of platelet derived growth factor and basic fibroblast growth factor by arterial smooth muscle cells. Eur J Vasc Surg. 1994;8:138-142.
32. Köster R, Windstetter Überfuhr P, Baumann G, Nikol S, Höfling B. Enhanced migratory activity of vascular smooth muscle cells with high expression of platelet-derived growth factor A and B. Angiology. 1995; 46:99-106.
33. Murry CE, Bartosek T, Giachelli CM, Alpers CE, Schwartz SM. Platelet-derived growth factor-A mRNA expression in fetal, normal adult, and atherosclerotic human aortas: analysis by competitive polymerase chain reaction. Circulation. 1996;93:1095-1106.
34. Geng YJ, Libby P. Evidence for apoptosis in advanced human atheroma: colocalization with interleukin-1β-converting enzyme. Am J Pathol. 1995;147:251-266.
35. Isner JM, Kearney M, Bortman S, Passeri J. Apoptosis in human atherosclerosis and restenosis. Circulation. 1995;91:2703-2711.
36. Bennett MR, Evan GI, Schwartz SM. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest. 1995;95:2266-2274.
37. Björkerud S, Björkerud B. Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. Am J Pathol. 1996;149:367-380.
38. Hegyi L, Skepper JN, Cary NRB, Mitchinson MJ. Form cell apoptosis and the development of the lipid core of human atherosclerosis. J Pathol. 1996;180:423-429.
39. Müller A, Hacker J, Brand BC. Evidence for apoptosis of human macrophage-like HL-60 cells by Legionella pneumophila infection. Infect Immun. 1996;64:4900-4906.
40. Moxon ER. Microbes, molecules and man: The Mitchell Lecture. 1992. J R Coll Physicians Lond. 1993;27:169-174.
41. Gupta S, Leatham EW, Carrington D, Mendall MA, Kaski JC, Camm AJ. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation. 1997;96:404-407.
42. Gurfinkel E, Bozovich G, Daroca A, Beck E, Mautner B, for the ROXIS Study group. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. Lancet. 1997;350:404-407.